Company: BIAF
Filing Date: 2025-04-15
Form Type: DRS
Source: 0001641172-25-004915
Chunk: 215

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-15
Form: DRS
Chunk 215
---
1, which Exhibit Index is incorporated herein by reference.

(b) Financial Statement Schedules

Schedules not listed have been omitted because the information required to be set forth therein is not applicable, not material or is shown in the financial statements or notes thereto.

Item 17. Undertakings

The undersigned registrant hereby undertakes:

| (1) | To                                                                                                                          
 file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |

| i.   | to                                                                                                                                     
 include any prospectus required by Section 10(a)(3) of the Securities Act;                                                             |
| ii.  | to                                                                                                                                     
 reflect in the prospectus any acts or events arising after the effective date of this registration statement (or the most recent       
 post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set       
 forth in this registration statement (notwithstanding the foregoing, any increase or decrease in volume of securities offered (if      
 the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end    
 of the estimated maximum offering range may be reflected in the form of a prospectus filed with the Commission pursuant to Rule 424(b) 
 under the Securities Act if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum      
 aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement);            
 and                                                                                                                                    |
| iii. | to                                                                                                                                     
 include any material information with respect to the plan of distribution not previously disclosed in this registration statement      
 or any material change to such information in this registration statement; provided, however, that subparagraphs (i), (ii) and (iii)   
 do not apply if the information required to be included in a post-effective amendment by those subparagraphs is contained in periodic  
 reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange 
 Act of 1934, that are incorporated by reference in this registration statement, or is contained in a form of prospectus filed pursuant 
 to Rule 424(b) that is part of the registration statement.                                                                             |

| (2) | That,                                                                                                                                     
 for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a         
 new registration statement relating to the securities offered therein, and the